Neogen Chemicals Publishes Newspaper Corrigendum to EGM Notice for Rs. 161 Crore Issue
Neogen Chemicals has published mandatory newspaper advertisements regarding the corrigendum to its EGM notice scheduled for March 29, 2026, addressing stock exchange clarifications on its Rs. 161 crore preferential issue. The funds will primarily support Neogen Ionics Limited's battery materials facility with Rs. 100 crore investment, alongside Rs. 21 crore for working capital and Rs. 40 crore for general corporate purposes.

*this image is generated using AI for illustrative purposes only.
Neogen chemicals has published newspaper advertisements regarding the corrigendum to its Extraordinary General Meeting (EGM) notice, following the comprehensive clarifications issued in response to stock exchange queries about its proposed Rs. 161.00 crore preferential issue.
Regulatory Compliance and Publication Requirements
Pursuant to Regulation 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the company published newspaper clippings in Financial Express (English Daily) and Mumbai Lakshadeep (Marathi Daily) on March 18, 2026. The advertisements provide corrigendum details for the EGM scheduled on March 29, 2026 at 11:30 a.m. (IST) through Video Conference/Other Audio-Visual Means (OAVM).
| Publication Details: | Information |
|---|---|
| English Daily: | Financial Express |
| Marathi Daily: | Mumbai Lakshadeep |
| Publication Date: | March 18, 2026 |
| Meeting Date: | March 29, 2026 |
| Meeting Time: | 11:30 a.m. (IST) |
The newspaper clippings have been uploaded to the company's website at https://neogenchem.com/announcements/ in the issue of securities tab, ensuring comprehensive accessibility for all stakeholders.
Enhanced Fund Utilization Details
The corrigendum provides comprehensive information on the utilization of issue proceeds totaling Rs. 161.00 crore across three key areas with specific deployment timelines:
| Object: | Amount (Rs. Crore) | Timeline |
|---|---|---|
| Investment in Neogen Ionics Limited: | 100.00 | Within 90 days from allotment |
| Working capital requirements: | 21.00 | Within 90 days from allotment |
| General corporate purposes: | 40.00 | Within 90 days from allotment |
The company has indicated that there may be variations not exceeding +/- 10% in the estimated amounts for each object. Pending utilization, proceeds will be invested in money market instruments or scheduled commercial bank deposits as permitted under applicable laws.
Neogen Ionics Limited - Battery Materials Strategy
The largest portion of funds, Rs. 100.00 crore, will be invested in Neogen Ionics Limited (NIL), a wholly-owned subsidiary incorporated on March 29, 2023. NIL focuses on battery chemicals business, particularly lithium-ion battery materials including electrolytes and lithium salts.
The subsidiary has acquired approximately 65 acres of land in Pakhajan, Dahej PCPIR, Gujarat, in December 2023 for establishing a battery materials facility. The comprehensive project includes:
- 30,000 MTA electrolyte capacity with MUIS Technology License
- 3,000 MTA specialty lithium electrolyte salts and additives at Pakhajan
- Additional 2,000 MTA electrolyte capacity at Dahej SEZ
- 2,500 MTA specialty lithium electrolyte salts/additives using indigenous technology
Project Economics and Investment Structure
| Parameter: | Details |
|---|---|
| Estimated Total Capex: | Rs. 1,500.00 crore |
| Peak Revenue Potential: | Rs. 2,500.00 - Rs. 2,950.00 crore |
| Investment Form: | Equity, convertible debentures, or combination |
| Deployment Method: | One or more tranches |
Promoter Group Changes and Allottee Details
The corrigendum provides detailed information about Cadamba Solutions Private Limited, incorporated on December 15, 2025, which belongs to the promoter group and is owned by promoter Dr. Harin Kanani. Cadamba is proposed to be allotted 10,00,000 equity shares at Rs. 1,610.00 per share, representing a premium over the floor price of Rs. 1,375.82 per share.
The document details inter-se transfers of shares executed on December 31, 2025, by promoter and promoter group members to their respective family trusts pursuant to SEBI exemption order WTM/KCV/CFD/17/2025-26:
| Transferor: | Transferee | Shares Transferred | Post-Transfer Holding |
|---|---|---|---|
| Haridas Kanani: | Haridas Kanani Family Trust | 52,76,500 | 8,77,387 (3.33%) |
| Haridas Kanani: | H T Kanani Family Trust | 5,02,000 | 3,75,387 (1.42%) |
| Beena Kanani: | Beena Kanani Family Trust | 26,38,250 | 2,74,691 (1.04%) |
Documentation and Compliance Framework
The company has confirmed that a certificate from DVD & Associates, Company Secretaries, certifying compliance with SEBI ICDR Regulations will be available for member inspection during the meeting and on the company website. The corrigendum emphasizes that all fund deployment will be completed within 90 days of equity share allotment.
Due to the inter-se transfers during the 90 trading days preceding the relevant date, Cadamba has made an application to SEBI pursuant to regulation 300 of SEBI ICDR regulations seeking exemption from strict application of regulation 159. The current and proposed status of Cadamba remains as promoter group member post the preferential issue.
Historical Stock Returns for Neogen Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.20% | -10.73% | +1.94% | -15.92% | -20.62% | +62.38% |


































